Cheng‐Tsung Liu

497 total citations
7 papers, 431 citations indexed

About

Cheng‐Tsung Liu is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Cheng‐Tsung Liu has authored 7 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 3 papers in Cellular and Molecular Neuroscience and 2 papers in Pharmacology. Recurrent topics in Cheng‐Tsung Liu's work include Synthesis and biological activity (4 papers), Synthesis and Biological Evaluation (3 papers) and Synthesis and Reactions of Organic Compounds (2 papers). Cheng‐Tsung Liu is often cited by papers focused on Synthesis and biological activity (4 papers), Synthesis and Biological Evaluation (3 papers) and Synthesis and Reactions of Organic Compounds (2 papers). Cheng‐Tsung Liu collaborates with scholars based in Taiwan. Cheng‐Tsung Liu's co-authors include Huey-Jiun Ko, Chun‐Nan Lin, Lo‐Ti Tsao, Jih-Pyang Wang, Jing‐Ru Weng, Shen‐Jeu Won, Che‐Ming Teng, Chun‐Nan Lin, I‐Hsun Li and Jih‐Pyang Wang and has published in prestigious journals such as European Journal of Pharmacology, European Journal of Medicinal Chemistry and Toxicology and Applied Pharmacology.

In The Last Decade

Cheng‐Tsung Liu

6 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cheng‐Tsung Liu Taiwan	5	311	112	88	50	37	7	431
Jih‐Pyang Wang Taiwan	7	220 0.7×	128 1.1×	77 0.9×	38 0.8×	29 0.8×	10	367
Vira M. Ubiyvovk Ukraine	9	226 0.7×	249 2.2×	61 0.7×	29 0.6×	15 0.4×	13	498
Jalinder V. Totre India	7	344 1.1×	69 0.6×	94 1.1×	32 0.6×	15 0.4×	7	432
Balaji L. Korbad India	12	380 1.2×	90 0.8×	133 1.5×	34 0.7×	12 0.3×	17	471
Mohamed N. Aboul‐Enein Egypt	15	370 1.2×	251 2.2×	110 1.3×	22 0.4×	24 0.6×	52	653
Pavel Bobáľ Czechia	15	337 1.1×	266 2.4×	61 0.7×	37 0.7×	21 0.6×	49	651
Atish H. Rodge India	11	387 1.2×	138 1.2×	67 0.8×	21 0.4×	9 0.2×	15	530
Avinash C. Tripathi India	13	433 1.4×	178 1.6×	133 1.5×	19 0.4×	32 0.9×	31	694
M. İhsan Han Türkiye	13	333 1.1×	132 1.2×	76 0.9×	28 0.6×	20 0.5×	26	493
Hai‐Shan Jin China	13	369 1.2×	94 0.8×	57 0.6×	50 1.0×	15 0.4×	28	446

Countries citing papers authored by Cheng‐Tsung Liu

Since Specialization

Citations

This map shows the geographic impact of Cheng‐Tsung Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Tsung Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Tsung Liu more than expected).

Fields of papers citing papers by Cheng‐Tsung Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheng‐Tsung Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Tsung Liu. The network helps show where Cheng‐Tsung Liu may publish in the future.

Co-authorship network of co-authors of Cheng‐Tsung Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Cheng‐Tsung Liu. A scholar is included among the top collaborators of Cheng‐Tsung Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheng‐Tsung Liu. Cheng‐Tsung Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Liu, Cheng‐Tsung, et al.. (2025). C18:0 GM3 ganglioside’s efficacy in LPS-induced parkinsonism: neuroprotection, inflammatory inhibition and gliosis mitigation. Behavioral and Brain Functions. 21(1). 25–25.

2.

Liu, Cheng‐Tsung, Li‐Ting Kao, Wu‐Chien Chien, et al.. (2019). The effect of dextromethorphan use in Parkinson's disease: A 6-hydroxydopamine rat model and population-based study. European Journal of Pharmacology. 862. 172639–172639. 12 indexed citations

3.

Liu, Cheng‐Tsung, Yuahn‐Sieh Huang, Hsin‐Chien Chen, et al.. (2019). Evaluation of brain SERT with 4-[18F]-ADAM/micro-PET and hearing protective effects of dextromethorphan in hearing loss rat model. Toxicology and Applied Pharmacology. 378. 114604–114604. 2 indexed citations

4.

Won, Shen‐Jeu, Cheng‐Tsung Liu, Lo‐Ti Tsao, et al.. (2005). Synthetic Chalcones as Potential Antiinflammatory and Cancer Chemopreventive Agents.. ChemInform. 36(22). 8 indexed citations

5.

Won, Shen‐Jeu, Cheng‐Tsung Liu, Lo‐Ti Tsao, et al.. (2004). Synthetic chalcones as potential anti-inflammatory and cancer chemopreventive agents. European Journal of Medicinal Chemistry. 40(1). 103–112. 246 indexed citations

6.

Ko, Huey-Jiun, et al.. (2004). Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation. Journal of Pharmacy and Pharmacology. 56(10). 1333–1337. 21 indexed citations

7.

Ko, Huey-Jiun, et al.. (2003). Structure–activity relationship studies on chalcone derivatives. Bioorganic & Medicinal Chemistry. 11(1). 105–111. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact